Mr. Speaker, Tuesday, December 12, 1995 will go down in history as a day of achievement and hope in the fight against AIDS.
Yesterday, Health Canada's Drugs Directorate approved, as part of a priority review process, the use of 3TC with Retrovir in the treatment of AIDS infections.
3TC was discovered by Biochem Pharma in Montreal and developed by Glaxo Wellcome. This is a Quebec achievement of which the whole scientific community can be proud.
I wish to express my sincere gratitude to Biochem Pharma for its research efforts of the past few years. They have not been in vain. I hope that this breakthrough will open the door to other discoveries that will not only significantly improve the quality of life of people with AIDS but also cure them.